echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Nat Commun: Extracellular matrix and adaptive adhesion dynamics jointly drive chemotherapy resistance in ovarian cancer

    Nat Commun: Extracellular matrix and adaptive adhesion dynamics jointly drive chemotherapy resistance in ovarian cancer

    • Last Update: 2021-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The biochemical and biomechanical factors derived from the extracellular matrix (ECM) in the tumor microenvironment (TME) are critical to the metastasis and treatment resistance of cancer cells


    The biochemical and biomechanical factors derived from the extracellular matrix (ECM) in the tumor microenvironment (TME) are critical to the metastasis and treatment resistance of cancer cells


    ECM can regulate the morphology, invasion, survival and growth of cancer cells


    ECM can regulate the morphology, invasion, survival and growth of cancer cells


    In this study, the researchers found that cisplatin chemotherapy can increase chemotherapy resistance by gradually changing the internal adhesion signals of cancer cells and the ECM around the cells


    Ovarian cancer

    HGSCs show strong ECM signals after chemotherapy

    HGSCs show strong ECM signals after chemotherapy

    In the systematic ECM screening of collagen-based 2D and 3D cell culture models, the researchers confirmed that specific ECM substrates and stiffness are enhanced by FAK and β1 integrin-pMLC-YAP signals to enhance resistance to cisplatin therapy and induce DNA damage Of apoptosis


    The researchers confirmed that specific ECM substrates and stiffness both enhance resistance to cisplatin treatment and apoptosis induced by DNA damage through FAK and β1 integrin-pMLC-YAP signaling


    Increased ECM stiffness protects HGSC cells against cisplatin treatment

    Increased ECM stiffness protects HGSC cells against cisplatin treatment

    All in all, the results of this study identified stroma adhesion as an adaptive response, and the study also revealed the mechanism of ECM pathway targeting stroma and tumors


    The results of this study identified stroma adhesion as an adaptive response, and the study also revealed the mechanism of ECM pathway targeting stroma and tumors



    Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance.







    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.